The summary of the research - clinical outcomes and survival differences between primary, secondary and concomitants carcinoma in situ of urinary bladder treated with BCG Immunotherapy is given below.
<h3>What is the summary of the above research?</h3>
Urinary bladder carcinoma in situ (CIS) is a flat, high-grade, and aggressive form of urothelial cancer with a high likelihood of development to muscle-invasive illness and metastatic dissemination.
The study's goal was to compare the clinical histories and survival rates of primary, secondary, and concurrent CIS of the bladder.
Learn more about Immunotherapy at brainly.com/question/14493516
#SPJ1
Answer:
To make text centered, select and highlight the text first, then hold down Ctrl (the control key) on the keyboard and press E. To make text right aligned, select and highlight the text first, then hold down Ctrl (the control key) on the keyboard and then press R.
Explanation:
Answer:
sort of
Explanation:
all the sites that allow you to message other people, even bots ,are all blocked , if youre trying to talk to a friend try sharing a google doc
